Genetic Association of CDC2 with Cerebrospinal Fluid Tau in Alzheimer’s Disease

We have recently reported that a polymorphism in the cell division cycle (CDC2) gene, designated Ex6 + 7I/D, is associated with Alzheimer’s disease (AD). The CDC2 gene is located on chromosome 10q21.1 close to the marker D10S1225 linked to AD. Active cdc2 accumulates in neurons containing neurofibrillary tangles (NFT), a process that can precede the formation of NFT. Therefore, CDC2 is a promising candidate susceptibility gene for AD. We investigated the possible effects of the CDC2 polymorphism on cerebrospinal fluid (CSF) biomarkers in AD patients. CDC2 genotypes were evaluated in relation to CSF protein levels of total tau, phospho-tau and β-amyloid(1–42) in AD patients and control individuals, and in relation to the amount of senile plaques and NFT in the frontal cortex and in the hippocampus in patients with autopsy-proven AD and controls. The CDC2 Ex6 + 7I allele was associated with a gene dose-dependent increase of CSF total tau levels (F2, 626 = 7.0, p = 0.001) and the homozygous CDC2 Ex6 + 7II genotype was significantly more frequent among AD patients compared to controls (p = 0.006, OR = 1.57, 95% CI 1.13–2.17). Our results provide further evidence for an involvement of cdc2 in the pathogenesis of AD.

[1]  Tin Tin Su,et al.  Cell Cycle Regulation , 2007, Fly.

[2]  K. Blennow,et al.  Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia , 2003, Neuroscience Letters.

[3]  Esther B. E. Becker,et al.  JNK Phosphorylation and Activation of BAD Couples the Stress-activated Signaling Pathway to the Cell Death Machinery* , 2002, The Journal of Biological Chemistry.

[4]  H. Braak,et al.  Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration , 2002, Acta Neuropathologica.

[5]  Maria K. Lehtinen,et al.  Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. , 2002, Molecular cell.

[6]  Marc W. Kirschner,et al.  Timing of Events in Mitosis , 2002, Current Biology.

[7]  R. Bowser,et al.  Altered subcellular distribution of transcriptional regulators in response to Aβ peptide and during Alzheimer's disease , 2001, Mechanisms of Ageing and Development.

[8]  J. Enghild,et al.  Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer’s disease pathology , 2001, Neurobiology of Aging.

[9]  K. Blennow,et al.  Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. , 2001, Archives of neurology.

[10]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[11]  M. Owen,et al.  Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.

[12]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[13]  G. Johnson,et al.  Tau Protein Is Hyperphosphorylated in a Site‐Specific Manner in Apoptotic Neuronal PC12 Cells , 2000, Journal of neurochemistry.

[14]  I. Vincent,et al.  Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases , 2000, Neurobiology of Aging.

[15]  K. Blennow,et al.  Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.

[16]  K. Blennow,et al.  Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[17]  David S. Park,et al.  Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death* , 1999, The Journal of Biological Chemistry.

[18]  K. Blennow,et al.  Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. , 1999, Archives of neurology.

[19]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[20]  J. Meyer,et al.  Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. , 1998, American journal of medical genetics.

[21]  Y. Kitamura,et al.  Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease , 1998, Brain Research.

[22]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[23]  A. Smith,et al.  Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.

[24]  G. Jicha,et al.  Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.

[25]  A. Hyman,et al.  Morphogenetic Properties of Microtubules and Mitotic Spindle Assembly , 1996, Cell.

[26]  K. Blennow,et al.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.

[27]  X. Graña,et al.  Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.

[28]  P. Greengard,et al.  Cell cycle‐dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. , 1994, The EMBO journal.

[29]  K. Imahori,et al.  A cdc2‐related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline‐directed protein kinase associated with microtubule , 1993, FEBS letters.

[30]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Braun,et al.  Proline-directed phosphorylation of human Tau protein. , 1992, The Journal of biological chemistry.

[32]  H. Feilotter,et al.  Regulation of the G2-mitosis transition. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[33]  J. Ávila,et al.  Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease , 1992, FEBS letters.

[34]  N. Thomas,et al.  Cell cycle regulation. , 1991, Blood reviews.

[35]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[36]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[37]  R. Nussbaum,et al.  Report of the committee on the genetic constitution of the X chromosome. , 1988, Cytogenetics and cell genetics.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  G. Lindwall,et al.  Phosphorylation affects the ability of tau protein to promote microtubule assembly. , 1984, The Journal of biological chemistry.

[40]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[41]  B. Winblad,et al.  Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis , 2004, Acta Neuropathologica.

[42]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[43]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[44]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[45]  H. Cann,et al.  Report of the committee on the genetic constitution of chromosome 10. , 1990, Cytogenetics and cell genetics.